In Small Study, New Treatment Brings Remission of Rectal Cancer in All Patients
MONDAY, June 6, 2022 (HealthDay News) — A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimabContinue Reading